Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1)

The summary for the Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1): The purpose of this FOA is to seek revision applications to cooperative agreements that are supporting networks or consortia of researchers who conduct or will be interested in conducting research in the following areas: The effectiveness of current human subjects protections and the development of tools and methods to examine evolving, evidence-based approaches to improve human subjects protections. The feasibility, costs, benefits, and impacts of requiring consent for research on deidentified human specimens and data using novel models of consent, e.g., notification, opt-out, opt-in, broad consent.

Federal Grant Title:	Limited Competition: Revision Applications to Advance Evidence-Based Research Related to Protections for Human Subjects (UL1)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAS-12-167
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.350
CFDA Descriptions:	National Center for Advancing Translational Sciences
Current Application Deadline:	May 25, 2012
Original Application Deadline:	May 25, 2012
Posted Date:	Apr 20, 2012
Creation Date:	Apr 20, 2012
Archive Date:	Jun 25, 2012
Total Program Funding:	$5,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctor...; • Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctora...; • Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science ...; • A Pre-application for the NIH-Industry Pilot Program: Discovering New Therapeutic Uses for...; • Limited Competition for NIH-Industry Pilot Program: Discovering New Therapeutic Uses for E...; • Limited Competition for NIH-Industry Pilot Program: Discovering New Therapeutic Uses for E...
More Grants from the National Institutes of Health: • Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Scie...; • New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not All...; • Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional); • Intervention Research to Improve Native American Health (R01 Clinical Trial Optional); • Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)